Ardiem Medical receives non-exclusive license to make and sell neuromodulation devices

NewsGuard 100/100 Score

Technology developed at Case Western Reserve University and the FES Center

Ardiem Medical Inc. has obtained a non-exclusive license to make and sell neuromodulation devices based on intellectual property developed at Case Western Reserve University's Department of Biomedical Engineering and the Functional Electrical Stimulation (FES) Center in Cleveland.

The agreement grants Ardiem Medical, a medical devices manufacturer based in Indiana, Pa., rights to intramuscular recording and stimulating electrodes, epimysysial recording and stimulating electrodes, spiral cuff peripheral nerve electrodes, and a universal external control unit. Additional details of the agreement were not disclosed.

Technologies first developed for internal research at Case Western Reserve and the FES Center will now be directly available through Ardiem to other researchers working in the neuromodulation field. Neuromodulation is among the fastest growing areas of medicine, involving many diverse specialties.

The 2009 two-volume book "Neuromodulation" explains that the technology's recent advancement has led to rapid growth of the neuromodulation device industry. P. Hunter Peckham, one of the book's editors, is Donnell Institute Professor of Biomedical Engineering and Orthopaedics at CWRU. Peckham serves as the director of the FES Center.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy